
The first new antibiotic for gonorrhea — the second most common sexually transmitted disease — has shown promise in a clinical trial. That news should come as a relief to public health experts, because gonorrhea has become resistant to all but one of the existing antibiotics used to treat it. This new antibiotic, called zoliflodacin,… read on > read on >